JP2023516284A5 - - Google Patents
Info
- Publication number
- JP2023516284A5 JP2023516284A5 JP2022550009A JP2022550009A JP2023516284A5 JP 2023516284 A5 JP2023516284 A5 JP 2023516284A5 JP 2022550009 A JP2022550009 A JP 2022550009A JP 2022550009 A JP2022550009 A JP 2022550009A JP 2023516284 A5 JP2023516284 A5 JP 2023516284A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021007184 | 2020-02-19 | ||
| IN202021007184 | 2020-02-19 | ||
| IN202021013770 | 2020-03-29 | ||
| IN202021013770 | 2020-03-29 | ||
| PCT/IN2021/050159 WO2021165992A1 (en) | 2020-02-19 | 2021-02-19 | Compositions and therapeutic uses of cannabidiol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023516284A JP2023516284A (ja) | 2023-04-19 |
| JPWO2021165992A5 JPWO2021165992A5 (https=) | 2024-07-09 |
| JP2023516284A5 true JP2023516284A5 (https=) | 2024-07-09 |
Family
ID=77391770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550009A Pending JP2023516284A (ja) | 2020-02-19 | 2021-02-19 | カンナビジオールの組成物および治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230123654A1 (https=) |
| EP (1) | EP4106870A4 (https=) |
| JP (1) | JP2023516284A (https=) |
| CN (1) | CN115916336A (https=) |
| AU (1) | AU2021223191A1 (https=) |
| CA (1) | CA3171890A1 (https=) |
| IL (1) | IL295753A (https=) |
| WO (1) | WO2021165992A1 (https=) |
| ZA (1) | ZA202210355B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL296892A (en) * | 2020-03-29 | 2022-12-01 | Akseera Pharma Corp | Interaction of sars-cov-2 proteins through a molecular or cellular mechanism of host cells and compounds for the treatment of covid -19 |
| AU2021250462A1 (en) * | 2020-04-02 | 2022-12-01 | Incannex Healthcare Limited | Methods and compositions for treating or preventing an inflammatory condition |
| WO2022122904A1 (en) * | 2020-12-09 | 2022-06-16 | Chanelle Mccoy Cbd Limited | A delayed-release capsule of cannabidiol |
| AU2022204290A1 (en) * | 2020-12-12 | 2023-07-27 | Akseera Pharma Corp. | Cannabidiol for augmenting vaccine mediated immunity and prophylaxis of covid-19 |
| IL309886A (en) * | 2021-07-15 | 2024-03-01 | Incannex Healthcare Ltd | A preparation containing cannabidiol and hydroxychloroquine in a combined capsule at a fixed dose |
| JPWO2024043242A1 (https=) * | 2022-08-23 | 2024-02-29 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087374B2 (en) * | 2003-06-26 | 2006-08-08 | The Research Foundation Of State University Of New York | Screen for sodium channel modulators |
| MX376077B (es) * | 2013-03-13 | 2025-03-07 | Univ Cincinnati | Tratamiento de una disfuncion cardiaca diastolica con un agonista del receptor trpv2. |
| WO2016161138A1 (en) * | 2015-03-31 | 2016-10-06 | Stamets Paul Edward | Antiviral activity from medicinal mushrooms and their active constituents |
| LT6486B (lt) * | 2016-04-13 | 2018-01-10 | UAB "SatiMed" | Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui |
| IL262713B2 (en) * | 2016-05-02 | 2024-07-01 | Stero Biotechs Ltd | Cannabidiol for reducing a steroid dose and treating inflammatory and autoimmune diseases |
| CN108079305A (zh) * | 2016-11-23 | 2018-05-29 | 汉义生物科技（北京）有限公司 | 大麻二酚与三环类抗抑郁药的药物组合物及其用途 |
| AU2018273410A1 (en) * | 2017-05-26 | 2020-01-16 | Altum Pharmaceuticals Inc. | Biphasix cannabinoid delivery |
| US20210085801A1 (en) * | 2017-12-12 | 2021-03-25 | Cardiol Therapeutics Inc. | Amphiphilic block copolymers, micelles, and methods for treating or preventing heart failure |
| KR102632946B1 (ko) * | 2018-01-13 | 2024-02-05 | 트루티바 인코포레이티드 | 노화 방지 및 피부 톤 미백 조성물 및 이를 위한 방법 |
| CN110575448A (zh) * | 2018-06-08 | 2019-12-17 | 云南汉素生物科技有限公司 | 大麻二酚组合物及其用途 |
| WO2020183456A1 (en) * | 2019-03-10 | 2020-09-17 | Bol Pharma Ltd. | Cannabinoid combinations for treating chronic pain in dialysis patients |
-
2021
- 2021-02-19 JP JP2022550009A patent/JP2023516284A/ja active Pending
- 2021-02-19 EP EP21756726.2A patent/EP4106870A4/en not_active Withdrawn
- 2021-02-19 CN CN202180029644.1A patent/CN115916336A/zh active Pending
- 2021-02-19 CA CA3171890A patent/CA3171890A1/en active Pending
- 2021-02-19 US US17/800,563 patent/US20230123654A1/en not_active Abandoned
- 2021-02-19 WO PCT/IN2021/050159 patent/WO2021165992A1/en not_active Ceased
- 2021-02-19 AU AU2021223191A patent/AU2021223191A1/en active Pending
- 2021-02-19 IL IL295753A patent/IL295753A/en unknown
-
2022
- 2022-09-19 ZA ZA2022/10355A patent/ZA202210355B/en unknown